☰

Keri E. Cannon, Ph.D. - Publications

Affiliations: 
2005 Albany Medical College of Union University 
Area:
Pain research
Tree Info Grants Similar researchers PubMed Report error

6/13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Edelmayer RM, Vanderah TW, Majuta L, Zhang ET, Fioravanti B, De Felice M, Chichorro JG, Ossipov MH, King T, Lai J, Kori SH, Nelsen AC, Cannon KE, Heinricher MM, Porreca F. Medullary pain facilitating neurons mediate allodynia in headache-related pain. Annals of Neurology. 65: 184-93. PMID 19259966 DOI: 10.1002/Ana.21537  0.306
2007 Cannon KE, Leurs R, Hough LB. Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively. Pharmacology, Biochemistry, and Behavior. 88: 122-9. PMID 17719621 DOI: 10.1016/J.Pbb.2007.07.014  0.717
2007 Cannon KE, Chazot PL, Hann V, Shenton F, Hough LB, Rice FL. Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets. Pain. 129: 76-92. PMID 17134835 DOI: 10.1016/J.Pain.2006.09.039  0.553
2005 Cannon KE, Hough LB. Inhibition of chemical and low-intensity mechanical nociception by activation of histamine H3 receptors. The Journal of Pain : Official Journal of the American Pain Society. 6: 193-200. PMID 15772913 DOI: 10.1016/J.Jpain.2004.12.003  0.72
2004 Cannon KE, Fleck MW, Hough LB. Effects of cimetidine-like drugs on recombinant GABAA receptors. Life Sciences. 75: 2551-8. PMID 15363660 DOI: 10.1016/J.Lfs.2004.05.020  0.601
2003 Cannon KE, Nalwalk JW, Stadel R, Ge P, Lawson D, Silos-Santiago I, Hough LB. Activation of spinal histamine H3 receptors inhibits mechanical nociception. European Journal of Pharmacology. 470: 139-47. PMID 12798951 DOI: 10.1016/S0014-2999(03)01737-0  0.484
Low-probability matches (unlikely to be authored by this person)
2014 Berman CL, Cannon K, Cui Y, Kornbrust DJ, Lagrutta A, Sun SZ, Tepper J, Waldron G, Younis HS. Recommendations for safety pharmacology evaluations of oligonucleotide- based therapeutics Nucleic Acid Therapeutics. 24: 291-301. PMID 24946015 DOI: 10.1089/nat.2013.0477  0.18
2014 Hudzik TJ, Cannon KE. Foreword Suicide: Phenomenology and Neurobiology. v. DOI: 10.1007/978-3-319-09964-4-a  0.12
2011 Cannon KE, Brabham T. The expanding biopharmaceutical field: Is CNS safety pharmacology doing enough? Journal of Pharmacological and Toxicological Methods. 64: e25. DOI: 10.1016/j.vascn.2011.03.091  0.053
2011 Tyszkiewicz CM, Cannon KE, Mead A. Optimizing learned helplessness testing conditions to detect changes in behavioral despair Journal of Pharmacological and Toxicological Methods. 64: e21-e22. DOI: 10.1016/J.Vascn.2011.03.078  0.041
2006 Hoogland JL, Cannon KE, DeBarbieri LM, Manno TG. Selective predation on Utah prairie dogs. The American Naturalist. 168: 546-52. PMID 17004225 DOI: 10.1086/507714  0.039
2014 Cannon KE, Hudzik TJ. Suicide: Phenomenology and neurobiology Suicide: Phenomenology and Neurobiology. 1-314. DOI: 10.1007/978-3-319-09964-4  0.021
2014 Hudzik TJ, Cannon KE. Introduction Suicide: Phenomenology and Neurobiology. 1-7. DOI: 10.1007/978-3-319-09964-4_1  0.01
Hide low-probability matches.